Hla-a2+ Restricted Peptide
Hla-a2+ Restricted Peptide Uses, Dosage, Side Effects, Food Interaction and all others data.
Hla-a2+ Restricted Peptide is under investigation in clinical trial NCT00524277 (Vaccine Therapy in Treating Patients With Breast Cancer).
| Trade Name | Hla-a2+ Restricted Peptide |
| Generic | GP2 peptide |
| GP2 peptide Other Names | Gp-2 her2-derived, hla-a2+ restricted peptide, GP2 peptide |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Hla-a2+ Restricted Peptide
